Search all trials

Find therapies in clinical trials near you – page 9

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Chronic lymphocytic leukaemia

Not recruiting

Registered drugNo placebo

Study on Acalabrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients Without del(17p) or TP53 Mutation

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Acalabrutinib

Contact Research Centre

Peripheral artery restenosis+4

Not recruiting

Registered drug

Study on the Effect of Clopidogrel and Acetylsalicylic Acid on Reducing Heart and Blood Vessel Events in Patients with Peripheral Arterial Disease

Registered drug

The Netherlands

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid

Contact Research Centre

Multiple sclerosis

Not recruiting

Registered drugNo placebo

Study on Personalized Dosing of Natalizumab for Patients with Relapsing-Remitting Multiple Sclerosis

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Natalizumab

Contact Research Centre

Acute myeloid leukaemia+1

Not recruiting

Registered drugNo placebo

Study Comparing Gilteritinib and Midostaurin with Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with FLT3 Mutation

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Gilteritinib

Contact Research Centre

K-ras gene mutation+2

Not recruiting

Registered drugNo placebo

Study Comparing Divarasib, Sotorasib, and Adagrasib for Patients with Advanced or Metastatic KRAS G12C-Positive Non-Small Cell Lung Cancer

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years

Contact Research Centre

Diffuse large B-cell lymphoma

Not recruiting

Registered drugNo placebo

Study Comparing Epcoritamab and Lenalidomide with a Drug Combination for Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Epcoritamab

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone with Lenalidomide and Dexamethasone for Patients with High-Risk Smoldering Multiple Myeloma

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Carfilzomib

Contact Research Centre

Inflammatory bowel disease

Not recruiting

Registered drugNo placebo

Study Comparing Infliximab Alone or with Immunosuppressive Drugs for Moderate to Severe Crohn's Disease Patients

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Infliximab

Contact Research Centre

Hormone receptor positive HER2 negative breast cancer+1

Not recruiting

Registered drugNo placebo

Study on Alpelisib and Fulvestrant for Advanced Breast Cancer in Patients with PIK3CA Mutation and Hormone-Receptor Positive, HER2 Negative Tumors

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Alpelisib

Contact Research Centre

Multiple sclerosis

Not recruiting

Registered drugNo placebo

Study on Personalized Ocrelizumab Dosing for Patients with Relapsing Remitting Multiple Sclerosis

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Ocrelizumab

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study on the Safety and Effects of PDC*lung01 Vaccine with Pemetrexed or Pembrolizumab for Patients with Non-Small Cell Lung Cancer

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Study on Reducing Side Effects in Advanced Hodgkin Lymphoma Using Brentuximab Vedotin and Drug Combination for Newly Diagnosed Patients

Not recruiting

Registered drugNo placebo

Study on Reducing Side Effects in Advanced Hodgkin Lymphoma Using Brentuximab Vedotin and Drug Combination for Newly Diagnosed Patients

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Bleomycin Sulfate

Contact Research Centre

Find therapies in clinical trials near you – page 9

147 trials match your criteria

Chronic lymphocytic leukaemia

Study on Acalabrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients Without del(17p) or TP53 Mutation

Peripheral artery restenosis+4

Study on the Effect of Clopidogrel and Acetylsalicylic Acid on Reducing Heart and Blood Vessel Events in Patients with Peripheral Arterial Disease

Multiple sclerosis

Study on Personalized Dosing of Natalizumab for Patients with Relapsing-Remitting Multiple Sclerosis

Acute myeloid leukaemia+1

Study Comparing Gilteritinib and Midostaurin with Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with FLT3 Mutation

K-ras gene mutation+2

Study Comparing Divarasib, Sotorasib, and Adagrasib for Patients with Advanced or Metastatic KRAS G12C-Positive Non-Small Cell Lung Cancer

Diffuse large B-cell lymphoma

Study Comparing Epcoritamab and Lenalidomide with a Drug Combination for Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Plasma cell myeloma

Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone with Lenalidomide and Dexamethasone for Patients with High-Risk Smoldering Multiple Myeloma

Inflammatory bowel disease

Study Comparing Infliximab Alone or with Immunosuppressive Drugs for Moderate to Severe Crohn's Disease Patients

Hormone receptor positive HER2 negative breast cancer+1

Study on Alpelisib and Fulvestrant for Advanced Breast Cancer in Patients with PIK3CA Mutation and Hormone-Receptor Positive, HER2 Negative Tumors

Multiple sclerosis

Study on Personalized Ocrelizumab Dosing for Patients with Relapsing Remitting Multiple Sclerosis

Non-small cell lung cancer

Study on the Safety and Effects of PDC*lung01 Vaccine with Pemetrexed or Pembrolizumab for Patients with Non-Small Cell Lung Cancer

Study on Reducing Side Effects in Advanced Hodgkin Lymphoma Using Brentuximab Vedotin and Drug Combination for Newly Diagnosed Patients

Study on Reducing Side Effects in Advanced Hodgkin Lymphoma Using Brentuximab Vedotin and Drug Combination for Newly Diagnosed Patients

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.